Dr. Wong obtained her PhD degree in HKU and completed her post-doctoral training at Johns Hopkins University. She is the recipient of the NSFC Distinguished Young Scholars Fund, NSFC Excellent Young Scientists Fund (Hong Kong and Macau), RGC Research Fellowship, Croucher Innovation Award, Hong Kong Young Scientist Award, the Rosie Young 90 Medal for Outstanding Young Woman Scholar, HKU Outstanding Young Researcher Award (OYRA), HKU Outstanding Research Student Supervisor Award (ORSSA), and Li Ka Shing Prize. Her research team is devoted to unraveling the complex mechanisms that drive metabolic reprogramming and immune evasion in liver cancer. Her team employs precision mouse models to gain a deeper understanding of personalized medicine for liver cancer, revealing how driver gene mutations of individual patients affect the immune characteristics and responses for immunotherapies. Her work has paved the way for precision medicine for liver cancer. Her team has also validated new immune checkpoints for liver cancer, providing the mechanistic rationales for new combination treatments in clinical trials. Her work was published in Gastroenterology, Gut, Journal of Hepatology, Hepatology, Nature Communications, Journal of Clinical Investigation, PNAS, Science Advances. She is the ESI top 1% most cited scholar in 2023-2025. She is an elected member of the Hong Kong Young Academy of Science. She currently serves as the co-editor-in-chief of Hepatology Communications (AASLD) and the editorial board member of Hepatology (AASLD) and CMGH. She is also the council member of the governing board of the International Liver Cancer Association (ILCA).
